Ravdin PM - Search Results

1

Cathepsin D by western blotting and immunohistochemistry: failure to confirm correlations with prognosis in node-negative breast cancer.

Ravdin PM, Tandon AK, Allred DC, Clark GM, Fuqua SA, Hilsenbeck SH, Chamness GC, Osborne CK. Ravdin PM, et al. J Clin Oncol. 1994 Mar;12(3):467-74. doi: 10.1200/JCO.1994.12.3.467. J Clin Oncol. 1994. PMID: 8120545

2

Prognosis and treatment decisions in patients with breast cancer without axillary node involvement.

McGuire WL, Tandon AK, Allred DC, Chamness GC, Ravdin PM, Clark GM. McGuire WL, et al. Among authors: ravdin pm. Cancer. 1992 Sep 15;70(6 Suppl):1775-81. doi: 10.1002/1097-0142(19920915)70:4+<1775::aid-cncr2820701619>3.0.co;2-8. Cancer. 1992. PMID: 1355403

3

A practical application of neural network analysis for predicting outcome of individual breast cancer patients.

Ravdin PM, Clark GM. Ravdin PM, et al. Breast Cancer Res Treat. 1992;22(3):285-93. doi: 10.1007/BF01840841. Breast Cancer Res Treat. 1992. PMID: 1391994

4

Treatment decisions in axillary node-negative breast cancer patients.

McGuire WL, Tandon AK, Allred DC, Chamness GC, Ravdin PM, Clark GM. McGuire WL, et al. Among authors: ravdin pm. J Natl Cancer Inst Monogr. 1992;(11):173-80. J Natl Cancer Inst Monogr. 1992. PMID: 1627425 Clinical Trial.

5

The c-erbB-2 proto-oncogene as a prognostic and predictive marker in breast cancer: a paradigm for the development of other macromolecular markers--a review.

Ravdin PM, Chamness GC. Ravdin PM, et al. Gene. 1995 Jun 14;159(1):19-27. doi: 10.1016/0378-1119(94)00866-q. Gene. 1995. PMID: 7607568 Review.

6

Prediction of axillary lymph node status in breast cancer patients by use of prognostic indicators.

Ravdin PM, De Laurentiis M, Vendely T, Clark GM. Ravdin PM, et al. J Natl Cancer Inst. 1994 Dec 7;86(23):1771-5. doi: 10.1093/jnci/86.23.1771. J Natl Cancer Inst. 1994. PMID: 7966415 Clinical Trial.

7

Lack of prognostic value of cathepsin D levels for predicting short term outcomes of breast cancer patients.

Ravdin PM, de Moor CA, Hilsenbeck SG, Samoszuk MK, Vendely PM, Clark GM. Ravdin PM, et al. Cancer Lett. 1997 Jun 24;116(2):177-83. doi: 10.1016/s0304-3835(97)00184-5. Cancer Lett. 1997. PMID: 9215861

8

Radiation therapy and survival in breast cancer patients with 10 or more positive axillary lymph nodes treated with mastectomy.

Diab SG, Hilsenbeck SG, de Moor C, Clark GM, Osborne CK, Ravdin PM, Elledge RM. Diab SG, et al. Among authors: ravdin pm. J Clin Oncol. 1998 May;16(5):1655-60. doi: 10.1200/JCO.1998.16.5.1655. J Clin Oncol. 1998. PMID: 9586875

9

Time-dependence of hazard ratios for prognostic factors in primary breast cancer.

Hilsenbeck SG, Ravdin PM, de Moor CA, Chamness GC, Osborne CK, Clark GM. Hilsenbeck SG, et al. Among authors: ravdin pm. Breast Cancer Res Treat. 1998;52(1-3):227-37. doi: 10.1023/a:1006133418245. Breast Cancer Res Treat. 1998. PMID: 10066085

10

A demonstration that breast cancer recurrence can be predicted by neural network analysis.

Ravdin PM, Clark GM, Hilsenbeck SG, Owens MA, Vendely P, Pandian MR, McGuire WL. Ravdin PM, et al. Breast Cancer Res Treat. 1992;21(1):47-53. doi: 10.1007/BF01811963. Breast Cancer Res Treat. 1992. PMID: 1391974

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

103 results

Search Page

Filters